
    
      The phase 1 in healthy volunteers include:

      SAD with 5 doses of test product and placebo

      MAD with 2 doses and two dosing intervals of the test product and placebo

      The safety, pharmacokinetics, pharmacodynamics and immunogenicity of the test product are
      evaluated.
    
  